Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3693544013 | Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3693545014 | Latanoprost 50 microgram/mL eye drops | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Topical form latanoprost | false | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has active ingredient | Latanoprost (substance) | false | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has active ingredient | Prostaglandin | false | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Product containing latanoprost in ophthalmic dosage form | false | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has manufactured dose form | Ocular dose form (dose form) | false | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has manufactured dose form | Eye drops | true | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has precise active ingredient | Latanoprost (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has basis of strength substance (attribute) | Latanoprost (substance) | true | Inferred relationship | Some | 1 | |
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Has concentration strength denominator unit | mL | true | Inferred relationship | Some | 1 | |
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Plays role | Antiglaucoma therapeutic role | true | Inferred relationship | Some | ||
Product containing precisely latanoprost 50 microgram/1 milliliter conventional release eye drops (clinical drug) | Is a | Latanoprost only product in ocular dose form | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets